These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7689681)

  • 21. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
    Labandeira-Garcia JL; Tobio JP; Guerra MJ
    Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS; Jian M
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
    Carta AR; Frau L; Pinna A; Morelli M
    Exp Neurol; 2010 Aug; 224(2):395-402. PubMed ID: 20452347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents.
    Mandel RJ; Wictorin K; Cenci MA; Björklund A
    Brain Res; 1992 Jun; 583(1-2):207-15. PubMed ID: 1504828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual role for Islet-1 in promoting striatonigral and repressing striatopallidal genetic programs to specify striatonigral cell identity.
    Lu KM; Evans SM; Hirano S; Liu FC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E168-77. PubMed ID: 24351932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus.
    Hoover BR; Marshall JF
    Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey.
    Selemon LD; Goldman-Rakic PS
    J Comp Neurol; 1990 Jul; 297(3):359-76. PubMed ID: 1697864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.
    Cenci MA; Tranberg A; Andersson M; Hilbertson A
    Neuroscience; 1999; 94(2):515-27. PubMed ID: 10579213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum.
    Rivera A; Trías S; Peñafiel A; Angel Narváez J; Díaz-Cabiale Z; Moratalla R; de la Calle A
    Brain Res; 2003 Oct; 989(1):35-41. PubMed ID: 14519509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of NMDA glutamate receptors in regulating D2 dopamine-dependent Fos induction in the rat striatopallidal pathway.
    Pollack AE; Bird JL; Lambert EB; Florin ZP; Castellar VL
    Brain Res; 1999 Feb; 818(2):543-7. PubMed ID: 10082844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
    Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN; Marshall JF
    Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.
    Araujo DM; Hilt DC; Miller PJ; Wen D; Jiao S; Lapchak PA
    Neuroscience; 1997 Sep; 80(1):9-16. PubMed ID: 9252216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc transport from the striatum and substantia nigra.
    Takeda A; Kodama Y; Ohnuma M; Okada S
    Brain Res Bull; 1998 Sep; 47(1):103-6. PubMed ID: 9766396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.